Dr. Anton Bilchik MD Specializes in Treatments for Better Outcomes for Patients with Pancreas and Liver Cancers

Tens of thousands of Americans are diagnosed every year with pancreas and liver cancer. According to the National Cancer Institute, over 45,000 people will be diagnosed with just pancreatic cancer this year alone. Sadly, pancreas cancer is especially aggressive and surgery offers the best opportunity for cure if detected early enough. More effective chemotherapeutic agents are now available for patients with more advanced disease.

Cancer centers of excellence provide better outcomes for patients battling these diseases. They typically a team of leading cancer surgeons and oncologists using the state of the art technology and treatments. Specialists, like Anton Bilchik MD, PhD, FACS, Professor of Surgery and Chief of Medicine at the John Wayne Cancer Institute, utilize their unique skillset to establish the most effective therapy for each patient to prolong survival.

The key to combating many cancers comes from comprehensive treatment from a multi-disciplinary team of surgeons, oncologists, and more. This enhanced collaboration between experts is where centers of excellence truly excel beyond other medical centers. Dedicated experts like Dr. Bilchik have access to a combination of the newest medicines, state-of-the-art technologies, and a team of fellow leaders in surgical oncology and gastrointestinal malignancies to find the most effective treatment for each patient.

As one of "America's Top Doctors," according to Castle Connolly Medical Ltd. And USA World News and Report, Anton Bilchik is internationally renowned as one of the top figures in modern oncology. He has received numerous awards and accolades around the world for his expertise in treating cancer, including his research into developing minimally invasive techniques to better treat patients and increase their chances for survival. He is dedicated to furthering research into the scientific understanding and treatment of liver and pancreatic cancer.

Despite the numerous difficulties often associated with liver or pancreatic cancers, cancer centers of excellence continue to provide the best opportunities for patients to recover and for the medical community to advance their ability to treat the diseases and more.

About Anton Bilchik MD:
Dr. Anton Bilchik is an internationally recognized leader in cancer research in surgical oncology and gastrointestinal malignancies. Dr. Bilchik is Professor of Surgery and Chief of Medicine at the John Wayne Cancer Institute and is also a Professor in Oncology at the David Geffen School of Medicine at UCLA. He is a pioneer of various surgical approaches for the staging of gastrointestinal cancers and minimally invasive surgeries to combat liver tumors. Dr. Bilchik has been the recipient of many awards and accolades for his accomplishments in the medical community, including the American Cancer Society. He is a member of the American Surgical Association. For more information, visit http://www.antonbilchikmd.com/ or follow him on Twitter.